Efficacy and safety of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma and extramedullary disease: Updated Phase 2 results from the redirectt-1 study with extended follow-up

Authors

Institutions

Publication Details

Journal
Blood
Published
2025-11-03
DOI
https://doi.org/10.1182/blood-2025-698
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and safety of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma and extramedullary disease: Updated Phase 2 results from the redirectt-1 study with extended follow-up

Moshe E. Gatt, Emma Scott, Nicholas T. Au, Michael Chu et al.
Blood
Multiple Myeloma Research and Treatments
article

Efficacy and safety of talquetamab + teclistamab in patients with Relapsed/Refractory multiple myeloma and extramedullary disease: Updated Phase 2 results from the redirectt-1 study with extended follow-up

Moshe E. Gatt, Emma Scott, Nicholas T. Au, Michael Chu, Saad Z. Usmani, M Festa, Todd Henninger, María‐Victoria Mateos, Shahzad Raza, Hila Magen, Shebli Atrash, Dok Hyun Yoon, Eva Medvedova, Laura Rosiñol Dachs, Tadao Ishida, Yael Chava Cohen, Paula Rodríguez‐Otero, Suzanne Trudel, Christoph Heuck, Maria Krevvata, Jiashen Lu, Hang Quach, Lin Huang, Lixia Pei, Jing Zhang, Joshua R. Richter, J Christine Ye, Lisa O’Rourke, Hun Chuah, Shaji Kumar, Jeffrey Matous, Koichi Onodera, Jiangxiu Zhou, Mikihiro Takamoto, Payal Thakkar, Carmela Maffucci
article en

Abstract

No abstract available for this paper.
BloodVol. 146(Supplement 1)
Alberta Health Services (CA), Cleveland Clinic (US), Mount Sinai Hospital (US), Sendai University (JP), Johnson & Johnson (United States) (US), The University of Texas MD Anderson Cancer Center (US), Rochester Institute of Technology (US), Oregon Health & Science University (US), Hebrew University of Jerusalem (IL), Royal Perth Hospital (AU), Tel Aviv Sourasky Medical Center (IL), Sheba Medical Center (IL), Hadassah Medical Center (IL), Princess Margaret Cancer Centre (CA), Kettering University (US), University of Ulsan (KR), St Vincent's Hospital Melbourne (AU), Mount Sinai Medical Center (US), Levine Cancer Institute (US), Sarah Cannon (US), Japanese Red Cross Medical Center (JP), Hospital Clínic de Barcelona (ES), Instituto de Investigación Biomédica de Salamanca (ES), Colorado Blood Cancer Institute (US), Clinica Universidad de Navarra (ES), Centro de Investigación del Cáncer (ES), Alberta Health (CA), Johnson & Johnson (United Kingdom) (GB), Johnson & Johnson (Netherlands) (NL), Centro de Investigación Biomédica en Red de Cáncer (ES), Johnson & Johnson (Brazil) (BR)
Openalex Percentile: Top 44%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.